Robert Driscoll analyst WEDBUSH

Currently out of the existing stock ratings of Robert Driscoll, 165 are a BUY (89.19%), 20 are a HOLD (10.81%).

Robert Driscoll

Work Performance Price Targets & Ratings Chart

Analyst Robert Driscoll works at WEDBUSH with a stock forecast success ratio of 42.38% fulfilled within 140.24 days on average.

Robert Driscoll’s has documented 364 price targets and ratings displayed on 34 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on BDTX, Black Diamond Therapeutics at 08-Apr-2024.

Wall Street Analyst Robert Driscoll

Analyst best performing recommendations are on ABUS (ARBUTUS BIOPHARMA CORP).
The best stock recommendation documented was for ABUS (ARBUTUS BIOPHARMA CORP) at 10/9/2018. The price target of $5 was fulfilled within 1 day with a profit of $1 (16.67%) receiving and performance score of 166.67.

Average potential price target upside

ABUS Arbutus Biopharma Corp AKAO Achaogen ARVN Arvinas BDTX Black Diamond Therapeutics CDTX Cidara Therapeutics CTMX CytomX Therapeutics ELEV Elevation Oncology ETTX Entasis Therapeutics Holdings FPRX Five Prime Therapeutics HARP Harpoon Therapeutics IDRA Idera Pharmaceuticals IDYA Ideaya Biosciences IGMS IGM Biosciences KURA Kura Oncology RCUS Arcus Biosciences REPL Replimune Group SURF Surface Oncology FHTX Foghorn Therapeutics  ACET Adicet Bio BCEL Atreca PRTK Paratek Pharmaceuticals ZNTL Zentalis Pharmaceuticals Llc CRVS Corvus Pharmaceuticals CMPX Compass Therapeutics . CYT Cyteir Therapeutics DAWN Day One Biopharmaceuticals IMGO Imago Biosciences GERN Geron JANX Janux Therapeutics NBRV Nabriva Therapeutics AG ALPN Alpine Immune Sciences OMGA Omega Therapeutics TNGX Tango Therapeutics TYRA Tyra Biosciences

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$0.91 (29.45%)


18 days ago

0/5 (0%)

$1 (33.33%)



$0.91 (29.45%)


1 months 21 days ago

1/8 (12.5%)

$1.21 (43.37%)




$1.91 (61.81%)


1 months 21 days ago

0/13 (0%)

$2.21 (79.21%)



$2.08 (71.23%)

2 years 2 months 20 days ago

0/1 (0%)

$2.11 (73.01%)



2 years 9 months 25 days ago

0/4 (0%)

$3.7 (112.12%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Robert Driscoll is most bullish on?

Potential upside of $21.35 has been obtained for ARVN (ARVINAS)

Which stock is Robert Driscoll is most reserved on?

Potential downside of -$14.63 has been obtained for JANX (JANUX THERAPEUTICS)

What Year was the first public recommendation made by Robert Driscoll?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?